Share Email Print

Proceedings Paper

Responses to hexyl 5-aminolevulinate-induced photodynamic treatment in rat bladder cancer model
Author(s): Carl-Jørgen Arum; Odrun Gederas; Eivind Larsen; Lise Randeberg; Chun-Mei Zhao
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

OBJECTIVES: In this study, we evaluated histologically the effects of hexyl 5-aminolevulinateinduced photodynamic treatment in the AY-27 tumor cell induced rat bladder cancer model. MATERIAL & METHODS: The animals (fischer-344 female rats) were divided into 2 groups, half of which were orthotopically implanted with 400,000 syngeniec AY-27 urothelia1 rat bladder cancer cells and half sham implanted. 14 days post implantation 6 rats from each group were treated with hexyl 5-aminolevulinate-induced photodynamic treatment (8mM HAL and light fluence of 20 J/cm2). Additional groups of animals were only given HAL instillation, only light treatment, or no treatment. All animals were sacrificed 7 days after the PDT/only HAL/only light or no treatment. Each bladder was removed, embedded in paraffin and stained with hematoxylin, eosin, and saferin for histological evaluation at high magnification for features of tissue damage by a pathologist blinded to the sample source. RESULTS: In all animals that were AY-27 implanted and not given complete PDT treatment, viable tumors were found in the bladder mucosa and wall. In the animals treated with complete HAL-PDT only 3 of 6 animals had viable tumor. In the 3 animals with viable tumor it was significantly reduced in volume compared to the untreated animals. It was also noted that in the PDT treated animals there was a significantly increased inflammatory response (lymphocytic and mononuclear cell infiltration) in the peri-tumor area compared to implanted animals without complete HAL-PDT. CONCLUSION: Our results suggest that hexyl 5-aminolevulinate-induced photodynamic treatment in a rat bladder cancer model involves both direct effects on cell death (necrosis and apoptosis) and indirect effects to evoke the host immune-response, together contributing to tumor eradication.

Paper Details

Date Published: 30 March 2010
PDF: 14 pages
Proc. SPIE 7548, Photonic Therapeutics and Diagnostics VI, 75481K (30 March 2010); doi: 10.1117/12.842222
Show Author Affiliations
Carl-Jørgen Arum, St. Olavs Hospital, Univ. Trondheim (Norway)
Norwegian Univ. of Science and Technology (Norway)
Odrun Gederas, Norwegian Univ. of Science and Technology (Norway)
Eivind Larsen, Norwegian Univ. of Science and Technology (Norway)
Lise Randeberg, Norwegian Univ. of Science and Technology (Norway)
Chun-Mei Zhao, Norwegian Univ. of Science and Technology (Norway)

Published in SPIE Proceedings Vol. 7548:
Photonic Therapeutics and Diagnostics VI
Anita Mahadevan-Jansen; Andreas Mandelis; Brian Jet-Fei Wong M.D.; Nikiforos Kollias; Henry Hirschberg M.D.; Kenton W. Gregory M.D.; Reza S. Malek; E. Duco Jansen; Guillermo J. Tearney; Steen J. Madsen; Bernard Choi; Justus F. R. Ilgner; Haishan Zeng; Laura Marcu, Editor(s)

© SPIE. Terms of Use
Back to Top